Colgate Palmolive Co 8-K, filed Mar 17, 2026
Colgate Palmolive Co (CL)
8-K
2026-03-17
For: 2026-03-17
View Original
Added on
April 08, 2026
About this 8-K
Colgate Palmolive Co filed this 8-K on March 17, 2026.
Items reported
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 17, 2026
(Exact name of registrant as specified in its charter)
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Securities 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01. Other Events.
As part of the previously announced Strategic Growth and Productivity Program, to further optimize and leverage the operating scale and drive growth within the Europe and Africa/Eurasia regions, effective for the quarter ending March 31, 2026, Colgate-Palmolive Company (the “Company”) has realigned its reportable operating segments. Commencing with the Company’s financial reporting for the quarter ending March 31, 2026, the results of its Europe and Africa/Eurasia (excluding Russia and Belarus) reportable operating segments and its Skin Health business (previously within the North America reportable operating segment) will be combined to form a new Europe, Middle East and Africa reportable operating segment. In conjunction with this realignment, Russia and Belarus, which were previously reported within the Africa/Eurasia reportable operating segment, will now be reported within the Asia Pacific reportable operating segment. This reportable operating segment realignment did not impact the Company’s historical consolidated results of operations, financial position or cash flows.
For information purposes and to provide investors with historical information on a basis consistent with its new reporting structure, the Company has recast its historical geographic segment information to conform to the new reporting structure.
Attached as Exhibit 99 and incorporated by reference in this Item 8.01 are schedules containing segment information by operating segment for the years ended December 31, 2025, 2024 and 2023, the three months ended March 31, 2025, the three and six months ended June 30, 2025 and the three and nine months ended September 30, 2025.
As noted above, the segment change and supplemental disclosures discussed above have no impact on the Company’s historical consolidated results of operations, financial position or cash flows. The recast financial information contained in Exhibit 99 does not represent a restatement of the Company’s previously issued financial statements. The information in this Item 8.01, including Exhibit 99, should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are filed with this document:
Exhibit Number | Description | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline eXtensible Business Reporting Language (Inline XBRL) document) | ||||
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
>
COLGATE-PALMOLIVE COMPANY | |||||||||||
Date: March 17, 2026 | By: | /s/ Stanley J. Sutula III | |||||||||
| Name: Stanley J. Sutula III | |||||||||||
| Title: Chief Financial Officer | |||||||||||
3
Exhibit 99
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 3,679 | $ | 1,510 | $ | 1,375 | $ | 4 | $ | 790 | |||||||
| Latin America | 4,776 | 2,107 | 1,268 | (11) | 1,411 | ||||||||||||
| Europe, Middle East & Africa | 4,276 | 1,572 | 1,686 | 80 | 938 | ||||||||||||
| Asia Pacific | 3,038 | 1,137 | 1,101 | (20) | 820 | ||||||||||||
Total Oral, Personal and Home Care(1) | 15,769 | 3,959 | |||||||||||||||
Pet Nutrition(2) | 4,613 | 1,818 | 1,717 | 14 | 1,064 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (1,717) | ||||||||||||||||
| Total | $ | 20,382 | $ | 3,306 | |||||||||||||
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,596 in 2025.
(2) Net sales in the United States for Pet Nutrition were $3,062 in 2025.
| Year Ended December 31, | |||||||||||||||||
| 2024 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 3,716 | $ | 1,476 | $ | 1,393 | $ | (9) | $ | 856 | |||||||
| Latin America | 4,782 | 1,933 | 1,328 | (5) | 1,526 | ||||||||||||
| Europe, Middle East & Africa | 4,046 | 1,511 | 1,637 | 85 | 814 | ||||||||||||
| Asia Pacific | 3,074 | 1,144 | 1,061 | (23) | 892 | ||||||||||||
Total Oral, Personal and Home Care(1) | 15,618 | 4,088 | |||||||||||||||
Pet Nutrition(2) | 4,483 | 1,869 | 1,641 | 8 | 965 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (784) | ||||||||||||||||
| Total | $ | 20,101 | $ | 4,268 | |||||||||||||
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,640 in 2024.
(2) Net sales in the United States for Pet Nutrition were $3,059 in 2024.
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| 2023 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 3,665 | $ | 1,489 | $ | 1,338 | $ | 4 | $ | 834 | |||||||
| Latin America | 4,640 | 1,977 | 1,241 | 5 | 1,417 | ||||||||||||
| Europe, Middle East & Africa | 3,822 | 1,537 | 1,460 | 71 | 754 | ||||||||||||
| Asia Pacific | 3,041 | 1,182 | 997 | (16) | 878 | ||||||||||||
Total Oral, Personal and Home Care(1) | 15,167 | 3,882 | |||||||||||||||
Pet Nutrition(2) | 4,290 | 1,964 | 1,493 | 26 | 806 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (704) | ||||||||||||||||
| Total | $ | 19,457 | $ | 3,984 | |||||||||||||
Note: Table may not sum due to rounding.
(1) Net sales in the United States for Oral, Personal and Home Care were $3,625 in 2023.
(2) Net sales in the United States for Pet Nutrition were $2,918 in 2023
| Years Ended December 31, | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| Capital expenditures | ||||||||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||||||||
| North America | $ | 63 | $ | 47 | $ | 45 | ||||||||||||||
| Latin America | 141 | 126 | 146 | |||||||||||||||||
| Europe, Middle East & Africa | 75 | 80 | 55 | |||||||||||||||||
| Asia Pacific | 82 | 64 | 65 | |||||||||||||||||
| Total Oral, Personal and Home Care | 361 | 317 | 311 | |||||||||||||||||
| Pet Nutrition | 88 | 143 | 301 | |||||||||||||||||
| Corporate | 115 | 101 | 93 | |||||||||||||||||
| Total Capital expenditures | $ | 564 | $ | 561 | $ | 705 | ||||||||||||||
| Years Ended December 31, | |||||||||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||||||||
| Depreciation and amortization | |||||||||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||||||||
| North America | $ | 77 | $ | 78 | $ | 79 | |||||||||||||||||
| Latin America | 106 | 100 | 98 | ||||||||||||||||||||
| Europe, Middle East & Africa | 122 | 119 | 111 | ||||||||||||||||||||
| Asia Pacific | 80 | 81 | 84 | ||||||||||||||||||||
| Total Oral, Personal and Home Care | 385 | 378 | 372 | ||||||||||||||||||||
| Pet Nutrition | 144 | 132 | 101 | ||||||||||||||||||||
| Corporate | 101 | 95 | 94 | ||||||||||||||||||||
| Total Depreciation and amortization | $ | 630 | $ | 605 | $ | 567 | |||||||||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 904 | $ | 358 | $ | 350 | $ | — | $ | 197 | |||||||
| Latin America | 1,143 | 487 | 316 | (7) | 348 | ||||||||||||
| Europe, Middle East & Africa | 1,007 | 367 | 399 | 18 | 222 | ||||||||||||
| Asia Pacific | 738 | 275 | 264 | (5) | 204 | ||||||||||||
| Total Oral, Personal and Home Care | 3,792 | 971 | |||||||||||||||
| Pet Nutrition | 1,118 | 437 | 422 | 1 | 258 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (153) | ||||||||||||||||
| Total | $ | 4,911 | $ | 1,076 | |||||||||||||
Note: Table may not sum due to rounding.
| Three Months Ended March 31, | ||||||||
| 2025 | ||||||||
| Capital expenditures | ||||||||
| Oral, Personal and Home Care | ||||||||
| North America | $ | 16 | ||||||
| Latin America | 28 | |||||||
| Europe, Middle East & Africa | 11 | |||||||
| Asia Pacific | 13 | |||||||
| Total Oral, Personal and Home Care | 68 | |||||||
| Pet Nutrition | 21 | |||||||
| Corporate | 35 | |||||||
| Total Capital expenditures | $ | 124 | ||||||
| Three Months Ended March 31, | |||||||||||
| 2025 | |||||||||||
| Depreciation and amortization | |||||||||||
| Oral, Personal and Home Care | |||||||||||
| North America | $ | 19 | |||||||||
| Latin America | 24 | ||||||||||
| Europe, Middle East & Africa | 29 | ||||||||||
| Asia Pacific | 20 | ||||||||||
| Total Oral, Personal and Home Care | 92 | ||||||||||
| Pet Nutrition | 31 | ||||||||||
| Corporate | 25 | ||||||||||
| Total Depreciation and amortization | $ | 148 | |||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Three Months Ended June 30, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 919 | $ | 380 | $ | 349 | $ | 3 | $ | 187 | |||||||
| Latin America | 1,207 | 527 | 318 | (6) | 367 | ||||||||||||
| Europe, Middle East & Africa | 1,083 | 395 | 428 | 19 | 241 | ||||||||||||
| Asia Pacific | 746 | 284 | 265 | (6) | 202 | ||||||||||||
| Total Oral, Personal and Home Care | 3,954 | 997 | |||||||||||||||
| Pet Nutrition | 1,157 | 462 | 430 | — | 264 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (181) | ||||||||||||||||
| Total | $ | 5,110 | $ | 1,080 | |||||||||||||
Note: Table may not sum due to rounding.
| Six Months Ended June 30, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 1,823 | $ | 737 | $ | 700 | $ | 3 | $ | 384 | |||||||
| Latin America | 2,350 | 1,014 | 633 | (13) | 715 | ||||||||||||
| Europe, Middle East & Africa | 2,089 | 762 | 827 | 38 | 463 | ||||||||||||
| Asia Pacific | 1,484 | 559 | 529 | (11) | 407 | ||||||||||||
| Total Oral, Personal and Home Care | 7,746 | 1,968 | |||||||||||||||
| Pet Nutrition | 2,275 | 899 | 852 | 1 | 523 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (334) | ||||||||||||||||
| Total | $ | 10,021 | $ | 2,156 | |||||||||||||
Note: Table may not sum due to rounding.
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||
| 2025 | 2025 | ||||||||||
| Capital expenditures | |||||||||||
| Oral, Personal and Home Care | |||||||||||
| North America | $ | 13 | $ | 29 | |||||||
| Latin America | 21 | 50 | |||||||||
| Europe, Middle East & Africa | 15 | 25 | |||||||||
| Asia Pacific | 19 | 32 | |||||||||
| Total Oral, Personal and Home Care | 68 | 136 | |||||||||
| Pet Nutrition | 22 | 43 | |||||||||
| Corporate | 18 | 53 | |||||||||
| Total Capital expenditures | $ | 108 | $ | 232 | |||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||
| 2025 | 2025 | |||||||||||||
| Depreciation and amortization | ||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||
| North America | $ | 19 | $ | 38 | ||||||||||
| Latin America | 27 | 51 | ||||||||||||
| Europe, Middle East & Africa | 30 | 58 | ||||||||||||
| Asia Pacific | 19 | 40 | ||||||||||||
| Total Oral, Personal and Home Care | 95 | 187 | ||||||||||||
| Pet Nutrition | 31 | 63 | ||||||||||||
| Corporate | 25 | 49 | ||||||||||||
| Total Depreciation and amortization | $ | 151 | $ | 299 | ||||||||||
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Three Months Ended September 30, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 922 | $ | 381 | $ | 342 | $ | (1) | $ | 199 | |||||||
| Latin America | 1,178 | 541 | 303 | (2) | 337 | ||||||||||||
| Europe, Middle East & Africa | 1,115 | 417 | 435 | 20 | 243 | ||||||||||||
| Asia Pacific | 775 | 288 | 280 | (6) | 213 | ||||||||||||
| Total Oral, Personal and Home Care | 3,989 | 992 | |||||||||||||||
| Pet Nutrition | 1,142 | 457 | 427 | 2 | 255 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (189) | ||||||||||||||||
| Total | $ | 5,131 | $ | 1,059 | |||||||||||||
Note: Table may not sum due to rounding.
| Nine Months Ended September 30, | |||||||||||||||||
| 2025 | |||||||||||||||||
| Net sales | Cost of Sales | Selling, general and administrative expenses | Other (income) expense, net | Operating Profit | |||||||||||||
| Reportable Segments | |||||||||||||||||
| Oral, Personal and Home Care | |||||||||||||||||
| North America | $ | 2,745 | $ | 1,119 | $ | 1,042 | $ | 2 | $ | 583 | |||||||
| Latin America | 3,528 | 1,555 | 936 | (15) | 1,052 | ||||||||||||
| Europe, Middle East & Africa | 3,204 | 1,179 | 1,261 | 58 | 706 | ||||||||||||
| Asia Pacific | 2,259 | 847 | 809 | (17) | 620 | ||||||||||||
| Total Oral, Personal and Home Care | 11,735 | 2,961 | |||||||||||||||
| Pet Nutrition | 3,417 | 1,356 | 1,280 | 4 | 778 | ||||||||||||
| Reconciliation with Total Company Operating Profit | |||||||||||||||||
| Corporate | (523) | ||||||||||||||||
| Total | $ | 15,152 | $ | 3,214 | |||||||||||||
Note: Table may not sum due to rounding.
| Colgate-Palmolive Company | ||||||||||||||||||||
| Segment Information (Recast) | ||||||||||||||||||||
| (Dollars in Millions) (Unaudited) | ||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2025 | 2025 | ||||||||||
| Capital expenditures | |||||||||||
| Oral, Personal and Home Care | |||||||||||
| North America | $ | 17 | $ | 46 | |||||||
| Latin America | 46 | 96 | |||||||||
| Europe, Middle East & Africa | 22 | 46 | |||||||||
| Asia Pacific | 18 | 51 | |||||||||
| Total Oral, Personal and Home Care | 103 | 239 | |||||||||
| Pet Nutrition | 21 | 64 | |||||||||
| Corporate | 31 | 84 | |||||||||
| Total Capital expenditures | $ | 155 | $ | 387 | |||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
| 2025 | 2025 | |||||||||||||
| Depreciation and amortization | ||||||||||||||
| Oral, Personal and Home Care | ||||||||||||||
| North America | $ | 20 | $ | 58 | ||||||||||
| Latin America | 27 | 78 | ||||||||||||
| Europe, Middle East & Africa | 30 | 89 | ||||||||||||
| Asia Pacific | 20 | 59 | ||||||||||||
| Total Oral, Personal and Home Care | 97 | 284 | ||||||||||||
| Pet Nutrition | 35 | 98 | ||||||||||||
| Corporate | 26 | 75 | ||||||||||||
| Total Depreciation and amortization | $ | 158 | $ | 457 | ||||||||||